AllianceRx is continuing to taking steps to help patients with chronic or complex conditions better manage their care online
EVERSANA™ has aggressively invested in technology, data and people to activate data-driven engagement to advance access and adherence at each stage of the product life cycle
INQOVI is for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies
FINTEPLA will be launched through a restricted distribution program, called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) Program, and is expected to be available through Zogenix’s specialty pharmacy partner Anovo
Biologics, as part of a recent reorganization, is now joining McKesson’s Provider Solutions business within the Pharmaceutical Solutions and Services (PSaS) business unit
OptimizeRx’s mission is to make healthcare more accessible to more patients by improving affordability and supporting adherence to prescribed treatment plans
Pharmaceutical manufacturers and payers have developed a number of agreements under which reimbursement is contingent on specific outcomes over the last few years
A new patented process for delivering specialty medicine will assure AllianceRx Walgreens Prime patients receive their medicine delivered at the correct temperature